Maravai Lifesciences Holdings (MRVI) Enterprise Value (2020 - 2026)

Maravai Lifesciences Holdings' Enterprise Value history runs 7 years deep, the most recent figure standing at -$8.4 million for Q1 2026.

• On a quarterly basis, Enterprise Value rose 84.83% year-over-year to -$8.4 million in Q1 2026; TTM through Mar 2026 was -$8.4 million, a 84.83% increase from a year earlier, with the FY2025 full-year figure at -$56.6 million, up 21.29% from the prior year.
• Enterprise Value rose to -$8.4 million in Q1 2026 per MRVI's latest filing, from -$56.6 million in the prior quarter.
• Across five years, Enterprise Value topped out at $379.1 million in Q1 2023 and bottomed at -$310.4 million in Q3 2024.
• The 5-year median for Enterprise Value is -$67.8 million (2025), against an average of -$37.8 million.
• Biggest YoY gain for Enterprise Value was 172.6% in 2022; the steepest drop was 218.38% in 2022.
• Year by year, Enterprise Value stood at -$272.1 million in 2022, then climbed by 25.83% to -$201.8 million in 2023, then soared by 64.4% to -$71.9 million in 2024, then advanced by 21.29% to -$56.6 million in 2025, then jumped by 85.14% to -$8.4 million in 2026.
• Per Business Quant, the three latest MRVI Enterprise Value figures stand at -$8.4 million (Q1 2026), -$56.6 million (Q4 2025), and -$57.2 million (Q3 2025).